Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
Hurvitz, Sara A, Dr, Andre, Fabrice, Prof, Jiang, Zefei, Prof, Shao, Zhimin, Prof, Mano, Max S, MD, Neciosup, Silvia P, MD, Tseng, Ling-Min, MD, Zhang, Qingyuan, Prof, Shen, Kunwei, Prof, Liu, Donggeng, Prof, Dreosti, Lydia M, Prof, Burris, Howard A, MD, Toi, Masakazu, Prof, Buyse, Marc E, Prof, Cabaribere, David, MSc, Lindsay, Mary-Ann, PhD, Rao, Shantha, PhD, Pacaud, Lida Bubuteishvili, MD, Taran, Tetiana, MD, Slamon, Dennis, Prof
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article